PRT543, a protein arginine methyltransferase 5 inhibitor, in patients with advanced adenoid cystic carcinoma: An open-label, phase I dose-expansion study

Autor: Ferrarotto, Renata, Swiecicki, Paul L., Zandberg, Dan P., Baiocchi, Robert A., Wesolowski, Robert, Rodriguez, Cristina P., McKean, Meredith, Kang, Hyunseok, Monga, Varun, Nath, Rajneesh, Palmisiano, Neil, Babbar, Naveen, Sun, William, Hanna, Glenn J.
Zdroj: In Oral Oncology February 2024 149
Databáze: ScienceDirect
Externí odkaz: